The table below shows Candel Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$9.84M
$8.46M
$6.99M
$4.02M
$5.42M
$4.98M
SG&A
CADL annual revenue (10-K history)
Candel Therapeutics, Inc. reported annual revenue of $125.00K for fiscal year 2022. That is up 0.0% from $125.00K in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.